Protagenic Therapeutics (PTIX) — Cash Flow Reinvestment Rate
Protagenic Therapeutics (PTIX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2010, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.72 Million. Explore reinvestment intensity of Protagenic Therapeutics to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Protagenic Therapeutics Cash Flow Reinvestment Rate (1999–2008)
Historical reinvestment intensity for Protagenic Therapeutics across 7 annual periods. Also explore Protagenic Therapeutics assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Protagenic Therapeutics (1999–2008)
Year-by-year capital reinvestment analysis for Protagenic Therapeutics. For live market cap and broader valuation context, see Protagenic Therapeutics (PTIX) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2008 | 0.47x | $2.03 Million | $4.36 Million | $2.03 Million | ▲ +463.3% |
| 2006 | 0.08x | $77.00K | $931.00K | $77.00K | ▼ -89.5% |
| 2003 | 0.79x | $1.48 Million | $1.87 Million | $1.48 Million | ▲ +4.1% |
| 2002 | 0.76x | $1.78 Million | $2.35 Million | $1.78 Million | ▼ -69.8% |
| 2001 | 2.52x | $3.79 Million | $1.50 Million | $3.79 Million | ▲ +173.6% |
| 2000 | 0.92x | $3.23 Million | $3.51 Million | $3.23 Million | ▲ +276.3% |
| 1999 | 0.24x | $81.00K | $331.00K | $81.00K | — |